No Data
No Data
Despite Delivering Investors Losses of 18% Over the Past 5 Years, HPGC Renmintongtai Pharmaceutical (SHSE:600829) Has Been Growing Its Earnings
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
HPGC Renmintongtai Pharmaceutical Corporation (600829.SH) has released its first-half performance, with a net income of 0.135 billion yuan, a decrease of 11.84% compared to the same period last year.
HPGC Renmintongtai Pharmaceutical Corporation (stock code: 600829.SH) released its semi-annual report for 2024, reporting a revenue of 4...
HPGC Renmintongtai Pharmaceutical Corporation (SHSE:600829) Will Pay A CN¥0.144 Dividend In Two Days
HPGC Renmintongtai Pharmaceutical Corporation (600829.SH)'s annual equity distribution in 2023 is 0.144 yuan per share. The registration of shareholders for dividend distribution will start on July 24th.
HPGC Renmintongtai Pharmaceutical Corporation (600829.SH) released the annual equity distribution announcement for 2023. The profit distribution for this period...
No Data
No Data